BioSpace News Archive

Additional results from the Phase 3 confirmatory clinical trial (OPTIC) of teprotumumab, an investigational medicine being developed by Horizon Therapeutics plc, will be presented at the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) 50th Anniversary 2019 Fall Scientific Symposium in San Francisco on Oct. 11.

Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, will highlight its rapidly growing AmplideX product portfolio and its novel data analysis software applications for challenging repetitive sequences at the upcoming American Society of Human Genetics (ASHG) Annual Meeting in Houston, Texas on October 15-19.

Genomind®, the leading mental health company bringing precision medicine into mainstream mental health treatment, today announced that it has created a variation of its industry-leading mental health pharmacogenomic (PGx) report that focuses solely on depression and anxiety.

Cyprio is the winner of Women Who Tech’s European-leg of its flagship Women Startup Challenge and will bring home an equity-free $50,000 cash grant.

Instrumentation Laboratory (IL) has been awarded Best System Performance in the Hemostasis category, as a part of the IMV ServiceTrak 2019 Clinical Laboratory Awards

Sonendo®, Inc., developer of the GentleWave® System, announced that they had recently been named as the fastest-growing company in the mid-size category by the Orange County Business Journal.

Hope Regional Cancer Center, has been awarded the prestigious three-year term of accreditation in radiation oncology as the result of a recent review by the American College of Radiology.

New Service Supports ATCC’s “Advancing Authentication” Initiative by Minimizing the Risk of Cell Line Misidentification and Cross-Contamination

As part of the innovative treatments offered through the Excelera Network, members granted immediate access to XPOVIO upon the treatment’s accelerated FDA approval in July 2019

MedMen and PharmaCann terminate business combination agreement